TGFB1 and neoplasm: Some of these inhibitory molecular mechanisms, such as IDO, PGE2, TGF-β, and IL-10, are shared with myeloid-derived suppressor cells, tumor cells, and infiltrating Treg lymphocytes present in TME [49,50].